Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Shares of Hikma Pharmaceuticals PLC HIK dropped 1.95% to £19.15 Tuesday, on what proved to be an all-around favorable trading ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million people worldwide Riyadh – Hikma Pharmaceuticals KSA, announced the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Zentalis Pharmaceuticals (ZNTL) announced the FDA has lifted the partial clinical hold on studies of azenosertib, the company's selective, and orally bioavailable inhibitor of WEE.

(RTTNews) - Vanda Pharmaceuticals (VNDA) said, on September 18, the FDA declined to approve New Drug Application of tradipitant for the treatment of symptoms in gastroparesis, providing the ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...

VICTORIA, BC, Sept. 19, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer ...

U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk's diabetes drug Ozempic for ...

Akums Drugs and Pharmaceuticals IPO Allotment: The initial public offering (IPO) of Akums Drugs and Pharmaceuticals Ltd has closed for subscription and has received strong demand from investors ...